VCI Wealth Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 5,937 shares of the exchange traded fund’s stock, valued at approximately $530,000.
Other hedge funds have also recently made changes to their positions in the company. EPG Wealth Management LLC grew its holdings in shares of SPDR S&P Biotech ETF by 152.7% during the third quarter. EPG Wealth Management LLC now owns 460 shares of the exchange traded fund’s stock valued at $34,000 after buying an additional 278 shares during the last quarter. Tennessee Valley Asset Management Partners purchased a new position in SPDR S&P Biotech ETF during the fourth quarter worth about $44,000. Wetzel Investment Advisors Inc. purchased a new position in SPDR S&P Biotech ETF during the fourth quarter worth about $45,000. Life Planning Partners Inc purchased a new position in SPDR S&P Biotech ETF during the fourth quarter worth about $64,000. Finally, Sheets Smith Wealth Management purchased a new position in SPDR S&P Biotech ETF during the third quarter worth about $55,000.
SPDR S&P Biotech ETF Stock Down 2.0 %
SPDR S&P Biotech ETF stock traded down $1.72 during midday trading on Thursday, hitting $82.22. 14,305,248 shares of the stock were exchanged, compared to its average volume of 11,739,715. SPDR S&P Biotech ETF has a 52-week low of $63.80 and a 52-week high of $103.52. The stock has a market capitalization of $6.39 billion, a price-to-earnings ratio of 11.47 and a beta of 1.08. The business’s 50-day moving average price is $92.88 and its 200-day moving average price is $84.55.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- How to Use the MarketBeat Stock Screener
- Hasbro’s Management Made All the Right Calls This Quarter
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- Trading Stocks: RSI and Why it’s Useful
- Power Surge: Utilities Sector’s Resilience Shines
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.